Clinical trial: switch to combined mycophenolate mofetil and minimal dose calcineurin inhibitor in stable liver transplant patients – assessment of renal and allograft function, cardiovascular risk factors and immune monitoring
V. R. CICINNATI; Z. YU; C. G. KLEIN; G. C. SOTIROPOULOS; F. SANER; M. MALAGÓ; A. FRILLING; G. GERKEN; C. E. BROELSCH; S. BECKEBAUM
- 作者V. R. CICINNATI; Z. YU; C. G. KLEIN; G. C. SOTIROPOULOS; F. SANER; M. MALAGÓ; A. FRILLING; G. GERKEN; C. E. BROELSCH; S. BECKEBAUM
- 卷第26卷
- 期第9期
- 印刷ISSN0269-2813
- 电子ISSN1365-2036
- 文件大小238.20KB
- 发表时间2007
- DOI10.1111/j.1365-2036.2007.03466.x
- 页码1195-1208